Nestlé Health Sciences to Invest $65 Million in a Boston Biotech Start-Up by MICHAEL J. DE LA MERCED

By MICHAEL J. DE LA MERCED

Nestlé Health Science will announce that it has invested $65 million in Seres, a Boston-based start-up focused on restoring the “microbiome,” the host of microorganisms that provide vital functions for humans.

Published: January 6, 2015 at 12:00AM

from NYT Business Day http://ift.tt/1s0S1UB

from WordPress http://ift.tt/1BFi1oF

via Hadi Aboukhater